Combatting COVID-19 with a little brown pill
As pharmaceutical companies around the world race to combat the coronavirus (COVID-19) pandemic with vaccines more are focusing on antiviral treatments with Merck leading the race. With more than 200 antiviral pills in development, Merck is the furthest along with their antiviral drug molnupiravir currently in clinical trials.
A covid pill could be coming sooner than you think. Think Tamiflu for covid. If Merck's drug works, it could be a gamechanger in the fight against this ever-mutating virus. w/@rileyraygriffin in this week's @BW $MRKhttps://t.co/Z2OWPVBqQe
— Cynthia Koons (@CynthiaLKoons) March 25, 2021
If proven safe and approved for use, molnupiravir will be a vital tool for doctors to help combat COVID-19 that is being compared to the Tamiflu treatment for the common flu. Merck’s little brown pill is currently in mid-stage with their clinical study with plans for larger trials to determine whether it prevents severe illness and death.
Molnupiravir’s journey for approval started in January before targeting the medication to be used for COVID-19 seeking funding to progress flu studies and explore the use of treatment for Ebola. Shortly after the release of early data for molnupiravir, the world shut down with COVID-19 lockdowns beginning around the world.
A pill reduced infectious virus in Covid-19 patients in a mid-stage study. Larger trials are under way exploring whether it prevents severe illness and death. https://t.co/R8i7ssSyyn
— The Wall Street Journal (@WSJ) March 6, 2021
After news of a worldwide lockdown, the demand for the drug was established with clinical trials for the pill starting in April. By May, Merck & Co. acquired the rights to molnupiravir from the initial developer, Ridgeback, and initiated the beginning of large-scale trials that began in the fall to be authorized by regulators.
Merck might be further in development with competition but other competitors are also gaining traction in clinical trials including Pfizer. The U.S. drugmaker has already successfully gained approval for emergency use by the FDA for the vaccine and recently announced they will be moving forward with human trials for their antiviral treatment. Pfizer’s oral antiviral drug can be used at the first sign of illness to prevent viral replication that works similar to other treatment drugs for Hepatitis C and HIV.
-
Credit: Shutterstock World on Edge as Russia Warns Trump and Iran Vows Never to Surrender As tensions in the...
-
Credit: Shutterstock Tensions Soar as Iran Launches 100 Drones at Israel Tensions in the Middle East reached a boiling...
-
Credit: Shutterstock Viral video reignites debate over Macron’s unconventional marriage during high-stakes diplomatic tour French President Emmanuel Macron and...
-
Tensions escalate between India and Pakistan as military strikes and air combat raise fears of a wider conflict in...
-
Credit: Pixabay A Powerful Portrait of Resilience Captures Global Attention and Reveals the Human Cost of War Through the...
-
A powerful earthquake strikes Southeast Asia, leaving thousands feared dead, buildings in ruins, and fears of catastrophic flooding on...
-
Japan Unveils the E10 Shinkansen – A High-Speed Revolution With British Design Japan has introduced the groundbreaking E10 Shinkansen,...
-
Avride Teams Up with Rakuten to Introduce Sidewalk Delivery Bots in Tokyo, Bringing Faster and More Efficient Deliveries to...
-
The World’s Most Expensive Substance Costs More Than the Global Economy Imagine a material so rare and difficult to...
-
May Mobility Launches Fully Driverless Ride-Hail Service in Peachtree Corners May Mobility is taking autonomous transportation to the next...
-
What Caused the Plane Crash? The tragic crash of Azerbaijan Airlines Flight 190 in western Kazakhstan has left 38...
-
In a whirlwind 24 hours that rocked South Korea, President Yoon Suk Yeol’s surprise martial law declaration and its...